Published in Arterioscler Thromb Vasc Biol on August 01, 1996
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest (2000) 5.07
Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol (2002) 3.02
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol (2002) 2.22
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol (2003) 2.20
Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol (2009) 2.05
Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol (1999) 1.83
Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun (2000) 1.77
CD36: implications in cardiovascular disease. Int J Biochem Cell Biol (2007) 1.62
Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood (2011) 1.32
Effects of FXR in foam-cell formation and atherosclerosis development. Biochim Biophys Acta (2006) 1.26
Molecular basis of human CD36 gene mutations. Mol Med (2007) 1.23
Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis. Am J Pathol (2004) 1.17
CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol (2009) 1.15
The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci (2009) 1.10
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells. Atherosclerosis (2008) 1.04
Nrf2, a PPARγ alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria. PLoS Pathog (2011) 0.96
Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J Inflamm (Lond) (2005) 0.96
Deficiency of PXR decreases atherosclerosis in apoE-deficient mice. J Lipid Res (2011) 0.96
Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events. Haematologica (2011) 0.95
Macrophage activation and skeletal muscle healing following traumatic injury. J Pathol (2014) 0.91
Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunology (2002) 0.90
Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration. J Clin Invest (1999) 0.89
Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respir Res (2005) 0.88
Attenuated aerobic exercise capacity in CD36 deficiency. J Med Genet (2007) 0.84
Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production. Korean J Physiol Pharmacol (2009) 0.82
Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains. BMC Genomics (2006) 0.82
Clinical significance of macrophage phenotypes in cardiovascular disease. Clin Transl Med (2014) 0.82
CD36 ectodomain phosphorylation blocks thrombospondin-1 binding: structure-function relationships and regulation by protein kinase C. Arterioscler Thromb Vasc Biol (2012) 0.81
Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress. Clin Lipidol (2009) 0.79
Pharmacogenetic interaction between dexamethasone and Cd36-deficient segment of spontaneously hypertensive rat chromosome 4 affects triacylglycerol and cholesterol distribution into lipoprotein fractions. Lipids Health Dis (2010) 0.79
Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. Heart (2004) 0.76
Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat. Microvasc Res (2014) 0.76
Anti-inflammatory and antioxidant activities of the nonlipid (aqueous) components of sesame oil: potential use in atherosclerosis. J Med Food (2015) 0.76
Thrombospondins: A Role in Cardiovascular Disease. Int J Mol Sci (2017) 0.75
CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat Rev Nephrol (2017) 0.75
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest (2001) 5.72
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest (2000) 5.07
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med (2000) 5.05
A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem (1999) 4.61
CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol (1997) 3.52
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest (2000) 3.20
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem (2000) 2.85
CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med (1995) 2.34
The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med (2000) 2.15
CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci (1996) 2.02
Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood (1996) 1.93
Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J Biol Chem (1993) 1.80
Cancer and clotting--Trousseau's warning. N Engl J Med (1992) 1.78
Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest (1995) 1.75
Differential roles of CD36 and alphavbeta5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium. J Exp Med (2001) 1.70
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med (1986) 1.68
Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol (1995) 1.67
Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem (1995) 1.61
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest (1987) 1.53
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest (1984) 1.52
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med (1987) 1.50
Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem (1996) 1.41
Binding of plasminogen to extracellular matrix. J Biol Chem (1986) 1.38
Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. Mol Pharmacol (1999) 1.37
Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem (1998) 1.26
Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36. J Biol Chem (1995) 1.25
The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol (2004) 1.24
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest (1985) 1.24
Thrombospondin: a versatile multifunctional glycoprotein. Arteriosclerosis (1986) 1.19
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res (2002) 1.19
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. J Biol Chem (1985) 1.12
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med (1998) 1.11
Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Thromb Haemost (1995) 1.09
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest (2001) 1.08
Hypercoagulability in cancer. Hematol Oncol Clin North Am (1996) 1.07
Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell (1990) 1.07
The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Mol Cell Biochem (2002) 1.04
Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc Natl Acad Sci U S A (1991) 0.99
CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci (2000) 0.96
Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein. J Biol Chem (1990) 0.96
von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci U S A (1993) 0.95
CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin. Biochem Biophys Res Commun (1991) 0.94
Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol (1995) 0.94
A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood (1994) 0.93
Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. J Biol Chem (1986) 0.92
Antiphospholipid antibodies activate vascular endothelial cells. Lupus (1996) 0.90
Engagement of the Lewis X antigen (CD15) results in monocyte activation. Blood (1997) 0.85
Cell adhesion molecules: an overview. Cancer Invest (1998) 0.84
CD36 induction on human monocytes upon adhesion to tumor necrosis factor-activated endothelial cells. J Biol Chem (1995) 0.83
CD antigens 1993. Blood (1994) 0.81
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Exp Cell Res (1999) 0.81
CD antigens 1993. J Immunol (1994) 0.80
CD36 expression is altered in retinal pigment epithelial cells of the RCS rat. Exp Eye Res (1997) 0.80
Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies. Thromb Res (1996) 0.80
CD antigens 1993. Immunol Today (1994) 0.78
Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. J Thromb Haemost (2014) 0.78
P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol (2012) 0.77
Angiogenesis and atherosclerosis. The mandate broadens. Circulation (1999) 0.77
Phosphorescence and ODMR study of the binding interactions of acetylcholine receptor alpha-subunit peptides with alpha-cobratoxin. FEBS Lett (1992) 0.75
The second international congress on myeloproliferative and myelodysplastic syndromes. Leuk Res (2004) 0.75
Interstitial nephritis caused by methicillin. Studies in a case complicating staphylococcal sepsis with acute glomerulonephritis. Am J Clin Pathol (1981) 0.75
Hematology grants workshop-2001. Hematology Am Soc Hematol Educ Program (2001) 0.75
Principles of thromboregulation: control of platelet reactivity in vascular disease. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.75